Different modes of anthracycline interaction with topoisomerase II: Separate structures critical for DNA-cleavage, and for overcoming topoisomerase II-related drug resistance

This publication has 26 references indexed in Scilit:

• Mode of action of topoisomerase II-targeting agents at a specific DNA sequence: Uncoupling the DNA binding, cleavage and religation events
  Journal of Molecular Biology, 1992
• Teniposide and etoposide in previously untreated small-cell lung cancer: a randomized study.
  Journal of Clinical Oncology, 1991
• Comparison of dna cleavage induced by etoposide and doxorubicin in two human small‐cell lung cancer lines with different sensitivities to topoisomerase ii inhibitors
  International Journal of Cancer, 1990
• 9-Alkyl, morpholinyl anthracyclines in the circumvention of multidrug resistance
  European Journal of Cancer and Clinical Oncology, 1990
• In vitro evaluation of the potential of aclarubicin in the treatment of small cell carcinoma of the lung (SCCL)
  British Journal of Cancer, 1989
• Strand specificity of the topoisomerase II-mediated double-stranded DNA cleavage reaction
  Biochemistry, 1989
• H2O2 as a DNA fragmenting agent in the alkaline elution interstrand crosslinking and DNA-protein crosslinking assays
  Analytical Biochemistry, 1988
• Intensely potent anthracycline antibiotic oxaunomycin produced by a blocked mutant of the daunorubicin-producing microorganism.
  The Journal of Antibiotics, 1986
• Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase II
  Science, 1984
• Carrier-mediated transport of daunorubicin, adriamycin, and rubidazone in ehrlich ascites tumour cells
  Biochemical Pharmacology, 1978